Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CanSino Biologics Inc.
  6. News
  7. Summary
    6185   CNE100003F01

CANSINO BIOLOGICS INC.

(6185)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CanSino Biologics : Sees Swing to Profit in H1 on COVID-19 Vaccine Sales

07/19/2021 | 12:33am EDT


© MT Newswires 2021
All news about CANSINO BIOLOGICS INC.
09/10Cansino Biologics Inc. Announces Executive Changes
CI
09/07CANSINO BIOLOGICS : Indonesia approves J&J, Cansino COVID-19 vaccines for emerge..
RE
09/07SINOVAC BIOTECH : Mixing CanSinoBIO, Sinovac COVID shots induces stronger respon..
RE
09/06CORONAVIRUS PANDEMIC : Chinese developer shares efficacy of inhaled vaccines
PU
08/27CANSINO BIOLOGICS : COVID shot drives CanSinoBIO's first six-month profit since ..
RE
08/27Cansino Biologics Inc. Reports Audited Consolidated Earnings Results for the ..
CI
08/13CANSINO BIOLOGICS INC.(SHSE : 688185) added to Shanghai Stock Exchange A Share I..
CI
08/13CANSINO BIOLOGICS INC.(SHSE : 688185) added to Shanghai Stock Exchange Composite..
CI
08/13Certain A Shares of CanSino Biologics Inc. are subject to a Lock-Up Agreement..
CI
08/06CANSINO BIOLOGICS : CanSinoBIO COVID-19 says booster shot can reverse drop in an..
RE
More news
Analyst Recommendations on CANSINO BIOLOGICS INC.
More recommendations
Financials
Sales 2021 9 984 M 1 546 M 1 546 M
Net income 2021 5 282 M 818 M 818 M
Net cash 2021 5 073 M 786 M 786 M
P/E ratio 2021 13,0x
Yield 2021 0,00%
Capitalization 80 728 M 10 372 M 12 503 M
EV / Sales 2021 7,58x
EV / Sales 2022 2,71x
Nbr of Employees 726
Free-Float 37,1%
Chart CANSINO BIOLOGICS INC.
Duration : Period :
CanSino Biologics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANSINO BIOLOGICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 262,00 CNY
Average target price 308,77 CNY
Spread / Average Target 17,9%
EPS Revisions
Managers and Directors
Xue Feng Yu Chairman, Chief Executive Officer & GM
Jing Wang Chief Financial Officer & Board Secretary
Jiang Feng Li Chairman-Supervisory Board
Tao Zhu Executive Director, CSO & Deputy General Manager
Jun Qiang Li Senior Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CANSINO BIOLOGICS INC.48.44%10 734
CSL LIMITED8.88%101 783
WUXI BIOLOGICS (CAYMAN) INC.13.23%63 964
SAMSUNG BIOLOGICS CO.,LTD.10.90%52 982
BIOGEN INC.22.20%44 592
ALEXION PHARMACEUTICALS, INC.0.00%40 336